Attributable risk (AR)

Attributable risk (AR)

PED STEP2

PED STEP2

Eating disorders: Pathology review
Psychiatric emergencies: Pathology review
Attributable risk (AR)
Bias in interpreting results of clinical studies
Bias in performing clinical studies
Clinical trials
Confounding
DALY and QALY
Direct standardization
Disease causality
Incidence and prevalence
Indirect standardization
Interaction
Mortality rates and case-fatality
Odds ratio
Positive and negative predictive value
Prevention
Relative and absolute risk
Selection bias
Sensitivity and specificity
Study designs
Test precision and accuracy
Acyanotic congenital heart defects: Pathology review
Adrenal masses: Pathology review
Bacterial and viral skin infections: Pathology review
Bone tumors: Pathology review
Coagulation disorders: Pathology review
Congenital neurological disorders: Pathology review
Cyanotic congenital heart defects: Pathology review
Extrinsic hemolytic normocytic anemia: Pathology review
Eye conditions: Inflammation, infections and trauma: Pathology review
Eye conditions: Refractive errors, lens disorders and glaucoma: Pathology review
Headaches: Pathology review
Intrinsic hemolytic normocytic anemia: Pathology review
Leukemias: Pathology review
Lymphomas: Pathology review
Macrocytic anemia: Pathology review
Microcytic anemia: Pathology review
Mixed platelet and coagulation disorders: Pathology review
Nasal, oral and pharyngeal diseases: Pathology review
Nephritic syndromes: Pathology review
Nephrotic syndromes: Pathology review
Non-hemolytic normocytic anemia: Pathology review
Pediatric brain tumors: Pathology review
Pediatric musculoskeletal disorders: Pathology review
Platelet disorders: Pathology review
Renal and urinary tract masses: Pathology review
Seizures: Pathology review
Viral exanthems of childhood: Pathology review
Pharmacodynamics: Agonist, partial agonist and antagonist
Pharmacodynamics: Desensitization and tolerance
Pharmacodynamics: Drug-receptor interactions
Pharmacokinetics: Drug absorption and distribution
Pharmacokinetics: Drug elimination and clearance
Pharmacokinetics: Drug metabolism
Cystic fibrosis: Pathology review
Diabetes mellitus: Pathology review
HIV and AIDS: Pathology review
Obstructive lung diseases: Pathology review
Papulosquamous and inflammatory skin disorders: Pathology review
Antidiuretic hormone
Body fluid compartments
Movement of water between body compartments
Sodium homeostasis
Acid-base disturbances: Pathology review
Diabetes insipidus and SIADH: Pathology review
Electrolyte disturbances: Pathology review
Renal failure: Pathology review
Growth hormone and somatostatin
Childhood and early-onset psychological disorders: Pathology review
Breastfeeding
Central nervous system infections: Pathology review
Congenital TORCH infections: Pathology review
Jaundice: Pathology review
Respiratory distress syndrome: Pathology review
Ectoderm
Endoderm
Human development days 1-4
Human development days 4-7
Human development week 2
Human development week 3
Mesoderm
Cell cycle
DNA damage and repair
DNA mutations
DNA replication
DNA structure
Epigenetics
Gene regulation
Mitosis and meiosis
Nuclear structure
Transcription of DNA
Translation of mRNA
Hardy-Weinberg equilibrium
Independent assortment of genes and linkage
Inheritance patterns
Mendelian genetics and punnett squares
Autosomal trisomies: Pathology review
Disorders of sex chromosomes: Pathology review
Miscellaneous genetic disorders: Pathology review
Baroreceptors
Cardiac preload
Chemoreceptors
Renin-angiotensin-aldosterone system
Adrenal insufficiency: Pathology review
Congenital gastrointestinal disorders: Pathology review
Environmental and chemical toxicities: Pathology review
Gastrointestinal bleeding: Pathology review
GERD, peptic ulcers, gastritis, and stomach cancer: Pathology review
Inflammatory bowel disease: Pathology review
Medication overdoses and toxicities: Pathology review
Pneumonia: Pathology review
Shock: Pathology review
Supraventricular arrhythmias: Pathology review
Traumatic brain injury: Pathology review
Ventricular arrhythmias: Pathology review
Introduction to pharmacology
Androgens and antiandrogens
Estrogens and antiestrogens
Miscellaneous cell wall synthesis inhibitors
Protein synthesis inhibitors: Tetracyclines
Cell wall synthesis inhibitors: Penicillins
Antihistamines for allergies
Acetaminophen (Paracetamol)
Non-steroidal anti-inflammatory drugs
Antimetabolites: Sulfonamides and trimethoprim
Antituberculosis medications
Cell wall synthesis inhibitors: Cephalosporins
DNA synthesis inhibitors: Fluoroquinolones
DNA synthesis inhibitors: Metronidazole
Miscellaneous protein synthesis inhibitors
Protein synthesis inhibitors: Aminoglycosides
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Bronchodilators: Leukotriene antagonists and methylxanthines
Pulmonary corticosteroids and mast cell inhibitors
Glucocorticoids
Azoles
Anticonvulsants and anxiolytics: Barbiturates
Anticonvulsants and anxiolytics: Benzodiazepines
Nonbenzodiazepine anticonvulsants
Developmental milestones: Clinical
Disruptive, impulse-control and conduct disorders: Clinical
Eating disorders: Clinical
Elimination disorders: Clinical
Neurodevelopmental disorders: Clinical
Child abuse: Clinical
BRUE, ALTE, and SIDS: Clinical
Congenital heart defects: Clinical
Fever of unknown origin: Clinical
Kawasaki disease: Clinical
Pediatric bone and joint infections: Clinical
Pediatric constipation: Clinical
Pediatric ear, nose, and throat conditions: Clinical
Pediatric gastrointestinal bleeding: Clinical
Pediatric infectious rashes: Clinical
Pediatric lower airway conditions: Clinical
Pediatric ophthalmological conditions: Clinical
Pediatric orthopedic conditions: Clinical
Pediatric upper airway conditions: Clinical
Pediatric urological conditions: Clinical
Pediatric vomiting: Clinical
Adrenal masses and tumors: Clinical
Asthma: Clinical
Cystic fibrosis: Clinical
Diabetes mellitus: Clinical
Leukemia: Clinical
Lymphoma: Clinical
Pediatric allergies: Clinical
Pediatric bone tumors: Clinical
Seizures: Clinical
Sickle cell disease: Clinical
Chronic kidney disease: Clinical
Heart failure: Clinical
Hyperkalemia: Clinical
Hypernatremia: Clinical
Hypokalemia: Clinical
Hyponatremia: Clinical
Metabolic and respiratory acidosis: Clinical
Shock: Clinical
Mood disorders: Clinical
Congenital disorders: Clinical
Neonatal ICU conditions: Clinical
Neonatal jaundice: Clinical
Newborn management: Clinical
Perinatal infections: Clinical
Bleeding disorders: Clinical
Immunodeficiencies: Clinical
Brain tumors: Clinical
Meningitis, encephalitis and brain abscesses: Clinical
Toxidromes: Clinical
Vaccinations: Clinical

Key Takeaways

Attributable risk (AR) is a measure of the proportion of disease that can be attributed to a particular exposure. In other words, it's a way of estimating how much of an illness is caused by a particular risk factor.

There are a few different ways to calculate AR, but they all rely on the same basic principle: you start by looking at the number of people who have the disease and then subtracting the number of people who don't have the disease but would have if it weren't for the exposure. This gives you the number of people who actually got sick because of the exposure. Then you divide that number by the total number of people who were exposed to see what percentage of cases were caused by the exposure.